| Year | 2024 |
|---|---|
| Total Revenue | 14.2M |
| Cost of Revenue | 8.99M |
| Gross Profit | 5.2M |
| Operating Expenses | 21.57M |
| Research and Development | 0 |
| Selling, General & Administrative Expenses | 500.12K |
| Selling & Marketing Expenses | 0 |
| General & Administrative Expenses | 500.12K |
| Other Expenses | 21.07M |
| Operating Income | -16.37M |
| Total Other Income/Expenses Net | 37.43M |
| Income Before Tax | 21.06M |
| Income Tax | 0 |
| Net Income | 21.06M |
| Basic EPS | 1.4 |
| EPS Diluted | 1.4 |
| Basic Average Shares | 15M |
| Diluted Average Shares | 15.04M |
| EBITDA | 24.45M |
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
NYSE
9.24USD0 (0%)
DCF Financial Statements
Retained Earning Schedule
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Retained Earnings (Previous Year) | -23.39M | -28.83M | -5.93M |
| Net Income | 21.06M | 13.71M | -13.99M |
| Stock Repurchases | 0 | 0 | 0 |
| Dividend Paid | -6.3M | -8.55M | -8.8M |
| Retained Earnings | -8.46M | -23.39M | -28.83M |
| Other Distributions | 8.63M | -3.11M | -31.7M |
PPE Schedule
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Gross PPE | 0 | 0 | 0 |
| Annual Depreciation | 40.82M | 167.9K | 228.49K |
| Capital Expenditure | -4 | 2 | 0 |
| Net PPE | -40.82M | -167.9K | -228.49K |
Intangible and Goodwill Schedule
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Acquisitions and Adjustments | 0 | 0 | 0 |
| Goodwill (Previous Year) | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 |